Development of Improved Version of Quality of Life Assessment Instrument for Lung Cancer Patients Based on Traditional Chinese Medicine (QLASTCM-Lu).
10.1007/s11655-018-2991-5
- Author:
Ting-Ting WANG
1
;
Li-Yun HE
2
;
Ming ZHANG
3
;
Shao-Mo WANG
4
;
Ai-Guang ZHAO
4
;
Lei CHU
5
;
Li-Yuan ZHANG
6
;
Sheng-Fu YOU
4
;
Jie YOU
7
Author Information
1. Department of Traditional Chinese Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
2. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100142, China.
3. Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, 200030, China.
4. Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
5. Department of Integrated Traditional and Western Medicine, Tumor Hospital of Qingdao, Qingdao, Shandong Province, 266042, China.
6. Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
7. Department of Traditional Chinese Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. yooujieyj@163.com.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
European Organization for Research and Treatment of Cancer;
lung cancer;
quality of life;
scale
- From:
Chinese journal of integrative medicine
2019;25(11):831-836
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To develop an improved version of the Quality-of-Life Assessment instrument for Lung Cancer Patients Based on Traditional Chinese Medicine (QLASTCM-Lu) and to evaluate its psychometric property.
METHODS:The structured group method and the theory in developing rating scale were employed to revise the preliminary scale. The psychometric property (reliability, validity, and responsiveness) of the established QLASTCM-Lu (modified) were evaluated by quality of life data measured in 100 lung cancer patients. Statistical analyses were made accordingly by way of correlation analysis, factor analysis and paired t-test.
RESULTS:The internal consistency reliability of the overall scale and all domains was from 0.80 to 0.94. Correlation and factor analyses demonstrated that the scale was good in construct validity. The criterion validity was formed with European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire-Lung Cancer (EORTC QLQ-LC43) as the criterion. Statistically significant changes were found apart from such domain as "mental condition" and "social function", with the standardized response means being close to those of QLQ-LC43.
CONCLUSION:QLASTCM-Lu (modified) could be used to measure the quality of life of lung cancer patients with good reliability, validity and a certain degree of responsiveness.
